T
Takuro Matsumoto
Researcher at Gifu University
Publications - 39
Citations - 285
Takuro Matsumoto is an academic researcher from Gifu University. The author has contributed to research in topics: Metastasis & Stromal cell. The author has an hindex of 8, co-authored 33 publications receiving 204 citations.
Papers
More filters
Journal ArticleDOI
Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma.
Nobuhiko Nakamura,Takeshi Hara,Yuhei Shibata,Takuro Matsumoto,Hiroshi Nakamura,Soranobu Ninomiya,Yusuke Kito,Junichi Kitagawa,Nobuhiro Kanemura,Naoe Goto,Makoto Shiraki,Tatsuhiko Miyazaki,Tamotsu Takeuchi,Masahito Shimizu,Hisashi Tsurumi +14 more
TL;DR: Sarcopenia is an independent prognostic factor in male patients with DLBCL who received the R-CHOP or R-THP-COP regimen between June 2004 and May 2014 and was measured by the analysis of CT images at the L3 level before treatment.
Journal ArticleDOI
High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia.
Ryoko Mabuchi,Takeshi Hara,Takuro Matsumoto,Yuhei Shibata,Nobuhiko Nakamura,Hiroshi Nakamura,Junichi Kitagawa,Nobuhiro Kanemura,Naoe Goto,Masahito Shimizu,Hiroyasu Ito,Yasuko Yamamoto,Kuniaki Saito,Hisataka Moriwaki,Hisashi Tsurumi +14 more
TL;DR: Multivariate analyses revealed that L-kynurenine and high leukocyte count were independent prognostic factors for AML, and in intermediate-risk cytogenetics patients, only L-dioxygenase was significantly associated with OS.
Journal ArticleDOI
Low Levels of Serum Tryptophan Underlie Skeletal Muscle Atrophy.
Soranobu Ninomiya,Nobuhiko Nakamura,Hiroshi Nakamura,Taku Mizutani,Yuto Kaneda,Kimihiro Yamaguchi,Takuro Matsumoto,Junichi Kitagawa,Nobuhiro Kanemura,Makoto Shiraki,Takeshi Hara,Masahito Shimizu,Hisashi Tsurumi +12 more
TL;DR: The data showed a critical role for tryptophan in regulating skeletal muscle mass and the tryPTophan metabolism pathway may be a promising target for preventing or treating skeletal muscle atrophies.
Journal ArticleDOI
R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial.
Takeshi Hara,Takeshi Yoshikawa,Hideko Goto,Michio Sawada,Toshiki Yamada,Kenji Fukuno,Senji Kasahara,Yuhei Shibata,Takuro Matsumoto,Ryoko Mabuchi,Nobuhiko Nakamura,Hiroshi Nakamura,Soranobu Ninomiya,Junichi Kitagawa,Nobuhiro Kanemura,Yasuhito Nannya,Naoki Katsumura,Takeshi Takahashi,Yusuke Kito,Tsuyoshi Takami,Tatsuhiko Miyazaki,Tamotsu Takeuchi,Masahito Shimizu,Hisashi Tsurumi +23 more
TL;DR: R‐THP‐COP was noninferior to R‐CHOP, as assessed by the primary endpoint of complete response rate, and has an acceptable safety profile, which indicates that this regimen may be an alternative therapy to R-CHOP.
Journal ArticleDOI
Prognostic impact of skeletal muscle assessed by computed tomography in patients with acute myeloid leukemia
Nobuhiko Nakamura,Soranobu Ninomiya,Takuro Matsumoto,Hiroshi Nakamura,Junichi Kitagawa,Makoto Shiraki,Takeshi Hara,Masahito Shimizu,Hisashi Tsurumi +8 more
TL;DR: Results indicate the prognostic values of sarcopenia in adult patients with newly diagnosed acute myeloid leukemia (AML) who received induction chemotherapy are high.